In mammals, ROS can promote tumor development and progression through two pathways: the mitogen-activated protein kinase (MAPK) and the phosphatidyl-inositol 3-kinase/protein kinase-B/target of rapamycin (PI3K/AKT/mTOR) [91]. The gene discussed is AKT1; the disease is neoplasm.